CitareTx Investment Partners
Venture capitalHouston · Seed · 2 people tracked
Find your way into CitareTx Investment Partners
Sign up to see every warm intro you have to CitareTx Investment Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CitareTx Investment Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
The firm focuses on Class II medical devices that can reach market through the FDA 510(k) pre-market notification process, with expertise spanning cardiovascular, interventional cardiology and radiology, cardiac and vascular surgery, critical care, and orthopedics. It prefers to form new start-ups around early technologies but will also invest in existing companies, taking an active operating role including board and executive management positions. Portfolio companies are typically collocated with the fund to share incubation resources across product design, development, testing, manufacture, and sale. Initial seed investments run roughly $0.5M-$2.0M in tranches, with follow-on capital under $5M before institutional growth funding or exit.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from public directoriesWhat they invest in
from 1 of 4 portfolio companiesDefense Tech ×1Hardware ×1Healthtech ×1Medical Devices ×1
HQs:United States×1
Investments · 4 tracked
founders shown can be your intro pathEMIT Corporation designs, manufactures, and sells FDA-cleared, CE-marked portable IV fluid and blood warming devices (HypothermX HX100/LG) that use a flameless hydrocarbon combustion process to treat and prevent hypothermia without generated power.
Defense TechHardwareHealthtechMedical DevicesHouston, US
BoardJeffery Sheldon(Executive Officer, Director)Elvin Jerome Pederson(Director)
Co-investorsUT Horizon Fund
Develops and commercializes image-guided hand-held medical robotics for therapeutic applications aimed at safer, cheaper, and more effective procedures.
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CoagulexCoauglex, Inc.
Frequently asked questions
- What stage does CitareTx Investment Partners invest at?
- CitareTx Investment Partners invests at the Seed stage.
- What is CitareTx Investment Partners's typical check size?
- CitareTx Investment Partners typically writes checks of $500K – $2M.
- What sectors does CitareTx Investment Partners focus on?
- CitareTx Investment Partners focuses on Healthtech, Medical Devices, Robotics.
- Where is CitareTx Investment Partners located?
- CitareTx Investment Partners is headquartered in Houston, US.
- Does CitareTx Investment Partners lead rounds?
- Yes, CitareTx Investment Partners leads investment rounds.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.


